Northwest Biotherapeutics NWBO
OTC NWBO
$0.15 +0.00 (+0.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

Northwest Biotherapeutics (NWBO) Total Non-Current Liabilities (2010 - 2026)

Updated

Northwest Biotherapeutics' Total Non-Current Liabilities came in at $37.37 million for Q2 2026, up 15.8% from $32.26 million a year earlier and up 6.3% from the prior quarter.

Analysis

Northwest Biotherapeutics (NWBO) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends

At the end of FY2025, Northwest Biotherapeutics' Total Non-Current Liabilities was $37.16 million, down 0.7% from FY2024.

  • Total Non-Current Liabilities carries a five-year compound annual growth rate of 22.6% (FY2020 to FY2025).
  • Going back by year, Total Non-Current Liabilities was $37.43 million in FY2024 (+26.0%), $29.72 million in FY2023 (+186.8%), $10.36 million in FY2022 (-65.9%) and $30.38 million in FY2021 (+126.3%).
  • The five-year range for quarterly Total Non-Current Liabilities is $10.07 million (Q3 2022) to $37.95 million (Q3 2025).
  • Year-over-year, Total Non-Current Liabilities increased in seven of the last eight quarters, with growth averaging 25.3%.
  • The fastest year-over-year change in Total Non-Current Liabilities over five years came in Q4 2023 (growth of 186.8%), and the weakest in Q4 2022 (a decline of 65.9%).
  • Business Quant data shows NWBO's Total Non-Current Liabilities at $35.14 million (Q1 2026), $37.16 million (Q4 2025) and $37.95 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 105.99 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 106.45 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -967.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 36.04 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.92 Bn
10 Northwest Biotherapeutics 250.40 Mn 240.41 Mn - 37.37 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 37.37 Mn
Mar 31, 2026 35.14 Mn
Dec 31, 2025 37.16 Mn
Sep 30, 2025 37.95 Mn
Jun 30, 2025 32.26 Mn
Mar 31, 2025 29.28 Mn
Dec 31, 2024 37.43 Mn
Sep 30, 2024 34.00 Mn
Jun 30, 2024 29.80 Mn
Mar 31, 2024 19.60 Mn
Dec 31, 2023 29.72 Mn
Sep 30, 2023 19.72 Mn
Jun 30, 2023 24.16 Mn
Mar 31, 2023 20.39 Mn
Dec 31, 2022 10.36 Mn
Sep 30, 2022 10.07 Mn
Jun 30, 2022 21.03 Mn
Mar 31, 2022 21.17 Mn
Dec 31, 2021 30.38 Mn
Sep 30, 2021 17.63 Mn
API Access

Northwest Biotherapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=NWBO&period=max&api_key=YOUR_API_KEY